We have data on 10 companies that use Covacsis. The companies using Covacsis are most often found in United States and in the Information Technology and Services industry. Covacsis is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for Covacsis usage goes back as far as 5 years and 11 months.
If you’re interested in the companies that use Covacsis, you may want to check out SAP Production Planning and Wonderware as well.
|Company||Covacsis Technologies Pvt. Ltd.|
|Company||Dixit Infotech Services Pvt Ltd|
|Company||Birlasoft (India) Ltd.|
|Company||Trident Technical College|
|Company||Progility Technologies Pvt Ltd.|
|Covacsis Technologies Pvt. Ltd.||covacsis.com||India||1M-10M||10-50|
|Dixit Infotech Services Pvt Ltd||disindia.com||India||10M-50M||200-500|
|Birlasoft (India) Ltd.||birlasoft.com||United States||200M-1000M||>10000|
|Trident Technical College||tridenttech.edu||United States||100M-200M||1000-5000|
|Progility Technologies Pvt Ltd.||progilitytech.com||India||None||200-500|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Manufacturing Engineering. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Manufacturing Engineering category, Covacsis has a market share of about 0.1%. Other major and competing products in this category include:
Covacsis Technologies has conceptualized, designed and implemented a technology framework to optimize operational as well as financial efficiency of a factory in real time.
Looking at Covacsis customers by industry, we find that Information Technology and Services (28%) is the largest segment.
50% of Covacsis customers are in United States and 41% are in India.
Of all the customers that are using Covacsis, 11% are small (<50 employees), 13% are medium-sized and 40% are large (>1000 employees).
Of all the customers that are using Covacsis, 11% are small (<$50M), 11% are medium-sized and 20% are large (>$1000M).